Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report) shares rose 1% during trading on Friday . The stock traded as high as $0.14 and last traded at $0.13. Approximately 17,101 shares were traded during trading, a decline of 6% from the average daily volume of 18,165 shares. The stock had previously closed at $0.13.
Guided Therapeutics Price Performance
The stock has a market cap of $8.69 million, a PE ratio of -4.43 and a beta of 0.61. The stock has a 50-day moving average price of $0.14 and a two-hundred day moving average price of $0.15.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Read More
- Five stocks we like better than Guided Therapeutics
- Stock Average Calculator
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Top Stocks Investing in 5G Technology
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- The 3 Best Fintech Stocks to Buy Now
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
